About
Therapies for Eye Disease
Areas of Focus
Categories
Biotech
Team (3)
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
60
By Phase
PHASE2: 1PHASE1/PHASE2: 1
By Status
ACTIVE_NOT_RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06003751Lead Sponsor
A Study of PER-001 in Participants With Diabetic Retinopathy
PHASE2Active, not recruiting
24 participants
Started: Aug 5, 2023 · Completed: Apr 30, 2026
NCT05822245Lead Sponsor
A Study of PER-001 in Participants With Open-Angle Glaucoma
PHASE1/PHASE2Active, not recruiting
36 participants
Started: May 25, 2023 · Completed: Apr 4, 2026
Locations (1)
Headquarters
San Francisco, CA, United States
Map
Loading map...